About Editas Medicine (EDIT)
Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. I... Read more
- USD1.57
- USD1.71
- USD1.53
- USD6.69
- 18.50%
- 32M
- 61.00
- 2.07M
- 129M
- 0.91
- -70.50%
Stock News
2 hours ago
Porsche cuts outlook on China woes, U.S. tariffs
MarketWatch
6 hours ago
Opera: Fantastic Results Prove Bull Case Is Just Getting Started
SeekingAlpha
6 hours ago
F5, Inc. Q2 Earnings: A Strong Free Cash Flow Machine At A Reasonable Price
SeekingAlpha
6 hours ago
Resilience Is The New Alpha: Rethinking Risk In A Fragile World
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
